Cyclacel Pharmaceuticals Inc (CYCC NASDAQ) stock market data APIs
$6.4137
0.35(5.5%)
as of September 11, 2025
Try our APIs with
free plan!
Cyclacel Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Prev. Close
6.4137
Open
6.7597
High
7.0017
Low
6.0736
52 wk Range
3.0801-283.4045
Market Cap
14 251 K
P/E Ratio
0.0009
Shares Outstanding
2 239 K
Revenue
10 000
EPS
-0.98
Dividends (Yield)
0
Beta
0.156
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cyclacel Pharmaceuticals Inc data using free add-ons & libraries
Get Cyclacel Pharmaceuticals Inc Fundamental Data
Cyclacel Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 10 000
- EBITDA: -10 355 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-13
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cyclacel Pharmaceuticals Inc News
New
Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.
KUALA LUMPUR, Malaysia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (Nasdaq: BGMS, Nasdaq: BGMSP) (“Bio Green Med” or the “Company”), a company engaged in diversified ind...
Oversold Conditions For Brown & Brown (BRO)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a te...
Cyclacel Pharmaceuticals declares $0.15 dividend
* Cyclacel Pharmaceuticals (NASDAQ:CYCC [https://seekingalpha.com/symbol/CYCC]) declares $0.15/share quarterly dividend [https://seekingalpha.com/pr/20200145-cyclacel-pharmaceuticals-reports-second-...
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
KUALA LUMPUR, Malaysia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
